Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription Articles published in Eur Radiol Retrieve available abstracts of 142 articles: HTML format

Single Articles

May 2026
1. YU W, Chen P, Chai S, Ding W, et al
   Deep learning model for noninvasive prediction of Ki-67 expression and prognostic stratification in breast cancer: a multicenter retrospective study.
   Eur Radiol. 2026 May 7. doi: 10.1007/s00330-025-12203.
   PubMed     Abstract available
   
   
   
2. MARTINIUSSEN MA, Bergan MB, Kristiansen MU, Moshina N, et al
   High risk score of breast cancer by artificial intelligence (AI) on screening mammograms: a review of negative and cancer cases.
   Eur Radiol. 2026 May 6. doi: 10.1007/s00330-026-12579.
   PubMed     Abstract available
   
   
   
3. WOO E, Lee JY, Seo BK, Bae MS, et al
   Diagnostic performance of shear-wave dispersion imaging and shear-wave elastography for differentiating benign and malignant breast masses.
   Eur Radiol. 2026;36:3378-3391.
   PubMed     Abstract available
   
   
   
4. NEETER LMFH, Lobbes MBI, Duvivier KM, Raat HPJF, et al
   Cost-effectiveness of contrast-enhanced mammography compared to conventional imaging in the work-up after screening (RACER trial).
   Eur Radiol. 2026;36:3396-3405.
   PubMed     Abstract available
   
   
   
5. APPELMAN L, Gil Quessep E, Veenendaal L, Siebers C, et al
   Contribution of mammographic imaging after initial ultrasound in women with focal breast complaints-systematic review.
   Eur Radiol. 2026;36:3346-3357.
   PubMed     Abstract available
   
   
   
6. HADIDCHI R, Agrawal A, Liu MZ, Maldijan T, et al
   A deep learning framework to stratify Nottingham histologic grade 2 breast tumors based on dynamic contrast-enhanced MRI.
   Eur Radiol. 2026;36:3335-3345.
   PubMed     Abstract available
   
   
   
7. SHENG W, Wang Y, Xiao L, Guo B, et al
   BI-RADS-compliant structured mammography reporting using locally deployed large language models under privacy constraints.
   Eur Radiol. 2026;36:3676-3686.
   PubMed     Abstract available
   
   
   April 2026
8. MAO K, Li Z, Li J, Xie Y, et al
   Mammography-based artificial intelligence model for predicting axillary lymph node status after neoadjuvant therapy in breast cancer.
   Eur Radiol. 2026 Apr 18. doi: 10.1007/s00330-026-12526.
   PubMed     Abstract available
   
   
   
9. XIE H, Wang X, Guo W, Wu Y, et al
   Prediction model to prevent axillary surgery using axillary US and MRI in early breast cancer.
   Eur Radiol. 2026 Apr 2. doi: 10.1007/s00330-026-12494.
   PubMed     Abstract available
   
   
   
10. VAN AMSTEL FJG, van Mierlo RGM, Nelemans PJ, Engelen SME, et al
    Publisher Correction: Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy.
    Eur Radiol. 2026 Apr 2. doi: 10.1007/s00330-026-12508.
    PubMed    
    
    
    March 2026
11. WOO E, Lee JY, Seo BK
    Reply to the Letter to the Editor: Shear-wave dispersion imaging in breast cancer: methodological considerations and future perspectives.
    Eur Radiol. 2026 Mar 16. doi: 10.1007/s00330-026-12471.
    PubMed    
    
    
    
12. OZTURK M, Gurun E
    Letter to the Editor: Shear-wave dispersion imaging in breast cancer: methodological considerations and future perspectives.
    Eur Radiol. 2026 Mar 16. doi: 10.1007/s00330-026-12470.
    PubMed    
    
    
    
13. VAN DER WAAL D, Abbey CK, Tetteroo E, Geertse TD, et al
    Finding the optimal recall rate in breast cancer screening: results from the ROCS study.
    Eur Radiol. 2026 Mar 5. doi: 10.1007/s00330-026-12370.
    PubMed     Abstract available
    
    
    
14. GEERTSE TD, Tetteroo E, Smid-Geirnaerdt MJA, Duijm LEM, et al
    Applying the "positive predictive value-recall diagram" to monitor performance and provide recommendations for screening radiologists.
    Eur Radiol. 2026;36:1919-1931.
    PubMed     Abstract available
    
    
    
15. SCHIAFFINO S, Bernardi D, Healy N, Marino MA, et al
    ESR Essentials: artificial intelligence in breast imaging-practice recommendations by the European Society of Breast Imaging.
    Eur Radiol. 2026;36:1909-1918.
    PubMed     Abstract available
    
    
    February 2026
16. EOM HJ, Kim HH, Kim SH, Gwon HY, et al
    Implant-displacement views alone for breast cancer screening in women with implants: a multicenter retrospective study.
    Eur Radiol. 2026 Feb 20. doi: 10.1007/s00330-026-12374.
    PubMed     Abstract available
    
    
    
17. LEHNEN T, Polenske D, Wichtmann BD, Lehnen NC, et al
    AI software as a third reader in breast cancer screening-a prospective diagnostic observational study.
    Eur Radiol. 2026 Feb 5. doi: 10.1007/s00330-026-12359.
    PubMed     Abstract available
    
    
    
18. LIU Y, Wu J, Zhang W, Wang T, et al
    Preoperative contrast-enhanced ultrasound combined with intra-lymph node methylene blue injection for sentinel lymph node identification: a minimally invasive sentinel lymph node biopsy tracing approach.
    Eur Radiol. 2026;36:863-873.
    PubMed     Abstract available
    
    
    
19. KIM HJ, Kim HH, Eom HJ, Choi WJ, et al
    Combined use of two artificial intelligence-based algorithms for mammography triaging: a retrospective simulation study.
    Eur Radiol. 2026;36:808-820.
    PubMed     Abstract available
    
    
    
20. JANSE MHA, Janssen LM, Wolters-van der Ben EJM, Moman MR, et al
    Deep learning-based radiomics does not improve residual cancer burden prediction post-chemotherapy in LIMA breast MRI trial.
    Eur Radiol. 2026;36:850-862.
    PubMed     Abstract available
    
    
    January 2026
21. LYTH J, Gialias P, Husberg M, Bernfort L, et al
    Results from a Swedish model-based analysis of the cost-effectiveness of AI-assisted digital mammography.
    Eur Radiol. 2026;36:754-764.
    PubMed     Abstract available
    
    
    
22. ANDERMAN KJ, Daly AE, Newman AM, Dang PA, et al
    Placement of radiofrequency identification tags: Is there an optimal tag-to-target distance?
    Eur Radiol. 2026;36:64-72.
    PubMed     Abstract available
    
    
    
23. SEXAUER R, Riehle F, Borkowski K, Ruppert C, et al
    Enhancing breast positioning quality through real-time AI feedback.
    Eur Radiol. 2026;36:55-63.
    PubMed     Abstract available
    
    
    
24. LIU G, Yang N, Qu Y, Chen G, et al
    Developing ultrasound-based machine learning models for accurate differentiation between sclerosing adenosis and invasive ductal carcinoma.
    Eur Radiol. 2026;36:33-44.
    PubMed     Abstract available
    
    
    December 2025
25. RODRIGUEZ DE TRUJILLO CAMPO-CO, Romero-Martin S, Rodriguez-Alonso B, Font-Ugalde P, et al
    Predictive factors of axillary pathological complete response in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy.
    Eur Radiol. 2025 Dec 24. doi: 10.1007/s00330-025-12241.
    PubMed     Abstract available
    
    
    
26. VAN AMSTEL FJG, van Mierlo RGM, Nelemans PJ, Engelen SME, et al
    Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy.
    Eur Radiol. 2025 Dec 23. doi: 10.1007/s00330-025-12249.
    PubMed     Abstract available
    
    
    
27. AYDEMIR DG, Molwitz I, Beitzen-Heineke A, Chen H, et al
    Right ventricular and biatrial CMR strain analysis detects myocardial functional impairment after breast cancer therapy.
    Eur Radiol. 2025 Dec 19. doi: 10.1007/s00330-025-12257.
    PubMed     Abstract available
    
    
    
28. SACCENTI L, El Bejjani L, Dao TH
    Postmastectomy radiotherapy for early-stage breast cancer: can imaging bring us closer to personalized care?
    Eur Radiol. 2025 Dec 17. doi: 10.1007/s00330-025-12201.
    PubMed    
    
    
    
29. NOGUEIRA L, Adubeiro N, Nunes RG
    Changing slopes: can we be moving toward improved early treatment response prediction in breast cancer?
    Eur Radiol. 2025 Dec 5. doi: 10.1007/s00330-025-12204.
    PubMed    
    
    
    November 2025
30. GATEWOOD J, Peterson J, Aripoli A, Huppe A, et al
    Can a low b-value diffusion-weighted imaging sequence replace the standard T2-weighted fluid-sensitive sequence in breast MRI? A single-center prospective study.
    Eur Radiol. 2025;35:7235-7243.
    PubMed     Abstract available
    
    
    October 2025
31. XU Z, Zhang Y, Zou Y, He Y, et al
    Identify high-risk patients of T1-2N1M0 breast cancer who benefit from postmastectomy radiotherapy: a dual-center retrospective propensity score-matched study.
    Eur Radiol. 2025 Oct 25. doi: 10.1007/s00330-025-12091.
    PubMed     Abstract available
    
    
    
32. SEKER ME, Ozkan O
    Navigating the future of mammography triaging: insights from combined usage of AI algorithms in breast cancer screening.
    Eur Radiol. 2025 Oct 24. doi: 10.1007/s00330-025-12095.
    PubMed    
    
    
    
33. ZHANG T, Liang X, Mann RM
    Multimodal artificial intelligence in breast cancer: towards integrated prediction and personalized care.
    Eur Radiol. 2025 Oct 22. doi: 10.1007/s00330-025-12085.
    PubMed    
    
    
    
34. SARDANELLI F, Scaperrotta G
    Artificial intelligence for breast cancer prevention: the vision ahead.
    Eur Radiol. 2025 Oct 8. doi: 10.1007/s00330-025-12036.
    PubMed     Abstract available
    
    
    
35. LI Y, Wang J, Guo J, Yue C, et al
    Longitudinal wash-in slope changes on dynamic contrast enhancement MRI for predicting response to neoadjuvant chemotherapy in breast cancer.
    Eur Radiol. 2025 Oct 3. doi: 10.1007/s00330-025-12042.
    PubMed     Abstract available
    
    
    
36. COZZI A, Di Leo G, Houssami N, Gilbert FJ, et al
    Preoperative breast MRI for invasive ductal carcinoma with or without a DCIS component at needle biopsy: influence on surgical outcomes in the MIPA study.
    Eur Radiol. 2025;35:6433-6443.
    PubMed     Abstract available
    
    
    
37. GOTO M, Le Bihan D, Sakai K, Yamada K, et al
    Reduction of biopsy rate in BI-RADS4 breast lesions: potential of an abbreviated advanced DWI protocol.
    Eur Radiol. 2025;35:6421-6432.
    PubMed     Abstract available
    
    
    
38. ALLAJBEU I, Nanaa M, Manavaki R, Papalouka V, et al
    Improving the diagnostic performance of contrast-enhanced mammography through lesion conspicuity and enhancement quantification.
    Eur Radiol. 2025;35:6385-6397.
    PubMed     Abstract available
    
    
    September 2025
39. YANG P, Wang M, Mao J, Cai P, et al
    Impact of intraoperative radiotherapy vs postoperative radiotherapy on survival in early-stage breast cancer patients.
    Eur Radiol. 2025 Sep 12. doi: 10.1007/s00330-025-11879.
    PubMed     Abstract available
    
    
    
40. TENDERO R, Larroza A, Perez-Benito FJ, Perez-Cortes JC, et al
    Breast cancer risk assessment for screening: a hybrid artificial intelligence approach.
    Eur Radiol. 2025 Sep 11. doi: 10.1007/s00330-025-11980.
    PubMed     Abstract available
    
    
    
41. HOVDA T, Larsen M, Bergan MB, Gjesvik J, et al
    Retrospective evaluation of a CE-marked AI system, including 1,017,208 mammography screening examinations.
    Eur Radiol. 2025;35:5685-5694.
    PubMed     Abstract available
    
    
    
42. JU Y, Zhang G, Wan Y, Wang G, et al
    Integration of AI lesion classification, age, and BI-RADS assessment to reduce benign biopsies on breast ultrasound.
    Eur Radiol. 2025;35:5658-5670.
    PubMed     Abstract available
    
    
    
43. AZCONA SAENZ J, Molero Calafell J, Roman Exposito M, Vall Foraster E, et al
    Preoperative estimation of the pathological breast tumor size in architectural distortions: a comparison of DM, DBT, US, CEM, and MRI.
    Eur Radiol. 2025;35:5635-5645.
    PubMed     Abstract available
    
    
    August 2025
44. KIDOH M, Hirai T
    Reply to the Letter to the Editor: Current role of the pericoronary fat attenuation index in breast cancer patients undergoing chemotherapy.
    Eur Radiol. 2025 Aug 22. doi: 10.1007/s00330-025-11960.
    PubMed    
    
    
    
45. ROTZINGER DC, Fahrni G
    Letter to the Editor: Current role of the pericoronary fat attenuation index in breast cancer patients undergoing chemotherapy.
    Eur Radiol. 2025 Aug 22. doi: 10.1007/s00330-025-11959.
    PubMed    
    
    
    
46. GIANNOTTI E, Pasculli M, Sella T, Van Ongeval C, et al
    ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging.
    Eur Radiol. 2025 Aug 14. doi: 10.1007/s00330-025-11819.
    PubMed     Abstract available
    
    
    
47. BOLAN PJ, Rahbar H, Partridge SC
    Can we cut the contrast? DWI shows similar value to standard MRI for assessing treatment response in breast cancer.
    Eur Radiol. 2025 Aug 7. doi: 10.1007/s00330-025-11912.
    PubMed    
    
    
    
48. SUBELACK J, Morant R, Blum M, Grawingholt A, et al
    Retrospective evaluation of interval breast cancer screening mammograms by radiologists and AI.
    Eur Radiol. 2025 Aug 4. doi: 10.1007/s00330-025-11833.
    PubMed     Abstract available
    
    
    
49. WAGNER T, Cockmartin L, Wang YK, Marshall N, et al
    A practical work around for breast density distribution discrepancies between mammographic images from different vendors.
    Eur Radiol. 2025;35:4885-4892.
    PubMed     Abstract available
    
    
    
50. LU F, Zhao Y, Wang Z, Feng N, et al
    Diagnostic accuracy of node-RADS for the detection of lymph node invasion: a systematic review and meta-analysis.
    Eur Radiol. 2025;35:4429-4437.
    PubMed     Abstract available
    
    
    July 2025
51. COZZI A, Di Leo G, Houssami N, Gilbert FJ, et al
    Preoperative breast MRI reduces reoperations for unilateral invasive lobular carcinoma: a patient-matched analysis from the MIPA study.
    Eur Radiol. 2025;35:3990-4000.
    PubMed     Abstract available
    
    
    
52. VAN DER VEER EL, Rozemond F, Generaal MI, Bluekens AMJ, et al
    Interhospital variations in diagnostic work-up following recall at biennial screening mammography-a population-based study.
    Eur Radiol. 2025;35:3964-3978.
    PubMed     Abstract available
    
    
    
53. JOHNSON K, Ikeda DM, Andersson I, Zackrisson S, et al
    Cancers not detected in one-view breast tomosynthesis screening-characteristics and reasons for non-detection.
    Eur Radiol. 2025;35:3951-3960.
    PubMed     Abstract available
    
    
    
54. HUANG J, He N, Li J, Chen J, et al
    Performance of contrast-enhanced cone-beam breast CT to predict nipple-areolar complex involvement in early-stage breast cancer.
    Eur Radiol. 2025 Jul 1. doi: 10.1007/s00330-025-11787.
    PubMed     Abstract available
    
    
    June 2025
55. TAIB AG, Partridge GJW, Yao L, Darker I, et al
    The evaluation of artificial intelligence in mammography-based breast cancer screening: Is breast-level analysis enough?
    Eur Radiol. 2025 Jun 25. doi: 10.1007/s00330-025-11733.
    PubMed     Abstract available
    
    
    
56. EOM HJ, Kim HH, Kim HJ, Choi WJ, et al
    Comparison of diffusion-weighted and contrast-enhanced MRI for monitoring response to neoadjuvant therapy in breast cancer.
    Eur Radiol. 2025 Jun 24. doi: 10.1007/s00330-025-11640.
    PubMed     Abstract available
    
    
    
57. VAN WINKEL SL, Samperna R, Loehrer EA, Drukker CA, et al
    Breast cancer in women after withdrawing from an increased-risk MRI screening program.
    Eur Radiol. 2025 Jun 12. doi: 10.1007/s00330-025-11718.
    PubMed     Abstract available
    
    
    
58. SANTONOCITO A, Zarcaro C, Zeitouni L, Ferrara F, et al
    A head-to-head comparison of breast lesion's conspicuity at contrast-enhanced mammography and contrast-enhanced MRI.
    Eur Radiol. 2025;35:3070-3079.
    PubMed     Abstract available
    
    
    May 2025
59. VERBOOM SD, Mainprize JG, Peters J, Broeders M, et al
    More than density: validating a mammographic masking prediction model in Dutch breast cancer screening.
    Eur Radiol. 2025 May 29. doi: 10.1007/s00330-025-11687.
    PubMed     Abstract available
    
    
    
60. THOMASSIN-NAGGARA I, Athanasiou A, Kilburn-Toppin F, Forrai G, et al
    Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosis.
    Eur Radiol. 2025;35:2397-2411.
    PubMed     Abstract available
    
    
    
61. ZARCARO C, Santonocito A, Zeitouni L, Ferrara F, et al
    Inter-reader agreement of the BI-RADS CEM lexicon.
    Eur Radiol. 2025;35:2378-2386.
    PubMed     Abstract available
    
    
    
62. NISSAN N, Gluskin J, Ochoa-Albiztegui RE, Fruchtman-Brot H, et al
    Performance of breast MRI for high-risk screening during lactation.
    Eur Radiol. 2025;35:2366-2375.
    PubMed     Abstract available
    
    
    
63. LIEBERT A, Schreiter H, Kapsner LA, Eberle J, et al
    Impact of non-contrast-enhanced imaging input sequences on the generation of virtual contrast-enhanced breast MRI scans using neural network.
    Eur Radiol. 2025;35:2603-2616.
    PubMed     Abstract available
    
    
    April 2025
64. ROMEO V, Rocco N
    A beneficial impact of pre-operative MRI in the surgical management of HER2-positive breast cancer.
    Eur Radiol. 2025 Apr 30. doi: 10.1007/s00330-025-11626.
    PubMed    
    
    
    
65. HUA B, Chen J, Wang Y, Hu P, et al
    Multivariable model to predict breast cancer in non-mass enhancement lesions: a study on contrast-enhanced mammography.
    Eur Radiol. 2025 Apr 17. doi: 10.1007/s00330-025-11597.
    PubMed     Abstract available
    
    
    
66. MA Y, Wang Y, Zhang Y, Bian K, et al
    Comparison of contrast-enhanced cone-beam breast CT, MRI, and mammography for breast cancer characterization.
    Eur Radiol. 2025 Apr 16. doi: 10.1007/s00330-025-11568.
    PubMed     Abstract available
    
    
    
67. XIA S, Hua Q, Song Y, Yuan C, et al
    Super-resolution ultrasound imaging of intranodal lymphatic sinuses for predicting sentinel lymph node metastasis in breast cancer: a preliminary study.
    Eur Radiol. 2025 Apr 5. doi: 10.1007/s00330-025-11520.
    PubMed     Abstract available
    
    
    
68. HONDA M, Sigmund EE, Le Bihan D, Pinker K, et al
    Advanced breast diffusion-weighted imaging: what are the next steps? A proposal from the EUSOBI International Breast Diffusion-weighted Imaging working group.
    Eur Radiol. 2025;35:2130-2140.
    PubMed     Abstract available
    
    
    
69. ALCANTARA R, Azcona J, Pitarch M, Arenas N, et al
    Breast radiation dose with contrast-enhanced mammography-guided biopsy: a retrospective comparison with stereotactic and tomosynthesis guidance.
    Eur Radiol. 2025;35:2119-2129.
    PubMed     Abstract available
    
    
    March 2025
70. KIM H, Choi JS, Chi SA, Ryu JM, et al
    Digital mammography with AI-based computer-aided diagnosis to predict neoadjuvant chemotherapy response in HER2-positive and triple-negative breast cancer patients: comparison with MRI.
    Eur Radiol. 2025 Mar 25. doi: 10.1007/s00330-025-11390.
    PubMed     Abstract available
    
    
    
71. EOM HJ, Choi WJ, Sun YJ, Kim HJ, et al
    Preoperative breast MRI in HER2-positive/hormone receptor-negative breast cancer: surgical outcomes using propensity score matching.
    Eur Radiol. 2025 Mar 20. doi: 10.1007/s00330-025-11494.
    PubMed     Abstract available
    
    
    
72. VALKOVIC ZUJIC P
    Challenges and variability in breast cancer screening: diagnostic work-up and strategies for standardization across Europe.
    Eur Radiol. 2025 Mar 5. doi: 10.1007/s00330-025-11425.
    PubMed    
    
    
    
73. BEZEK CD, Farkas M, Schweizer D, Kubik-Huch RA, et al
    Breast density assessment via quantitative sound-speed measurement using conventional ultrasound transducers.
    Eur Radiol. 2025;35:1490-1501.
    PubMed     Abstract available
    
    
    
74. VATTERONI G, Dietzel M, Baltzer PAT
    Can structured integration of BI-RADS criteria by a clinical decision rule reduce the number of unnecessary biopsies in BI-RADS 4 lesions? A systematic review and meta-analysis.
    Eur Radiol. 2025;35:1504-1513.
    PubMed     Abstract available
    
    
    February 2025
75. LOUIS FM, Sonke GS, Mann RM
    Image-guided adaption of systemic therapy in breast cancer patients.
    Eur Radiol. 2025 Feb 13. doi: 10.1007/s00330-025-11456.
    PubMed    
    
    
    
76. MALHAIRE C, Umay O, Cockenpot V, Selhane F, et al
    Predicting axillary residual disease after neoadjuvant therapy in breast cancer using baseline MRI and ultrasound.
    Eur Radiol. 2025 Feb 8. doi: 10.1007/s00330-025-11408.
    PubMed     Abstract available
    
    
    
77. ABDULLAH KA, Marziali S, Nanaa M, Escudero Sanchez L, et al
    Deep learning-based breast cancer diagnosis in breast MRI: systematic review and meta-analysis.
    Eur Radiol. 2025 Feb 5. doi: 10.1007/s00330-025-11406.
    PubMed     Abstract available
    
    
    
78. RANGARAJAN K, Manivannan VV, Singh H, Gupta A, et al
    Simulation training in mammography with AI-generated images: a multireader study.
    Eur Radiol. 2025;35:562-571.
    PubMed     Abstract available
    
    
    
79. LE BIHAN D, Iima M, Partridge SC
    Fat-signal suppression in breast diffusion-weighted imaging: the Good, the Bad, and the Ugly.
    Eur Radiol. 2025;35:733-741.
    PubMed     Abstract available
    
    
    
80. OKOLIE A, Dirrichs T, Huck LC, Nebelung S, et al
    Accelerating breast MRI acquisition with generative AI models.
    Eur Radiol. 2025;35:1092-1100.
    PubMed     Abstract available
    
    
    
81. ATHANASIOU A, Appelman L, Pijnappel RM, Gilbert FJ, et al
    ESR Essentials: diagnostic work-up in patients with symptomatic breast disease-practice recommendations by the European Society of Breast Imaging.
    Eur Radiol. 2025;35:723-732.
    PubMed     Abstract available
    
    
    
82. NISSAN N, Gluskin J, Ochoa-Albiztegui RE, Sung JS, et al
    Asymmetric background parenchymal enhancement on contrast-enhanced mammography: associated factors, diagnostic workup, and clinical outcome.
    Eur Radiol. 2025;35:712-722.
    PubMed     Abstract available
    
    
    January 2025
83. D'ANGELO A, Caprini F, Adele Marino M
    Current status of breast cancer screening in transgender and gender-diverse populations.
    Eur Radiol. 2025 Jan 31. doi: 10.1007/s00330-025-11355.
    PubMed    
    
    
    
84. NANAA M, Manavaki R, van Nijnatten TJA, Stranz N, et al
    Tumour growth rate and invasive interval cancer characteristics in a UK breast cancer screening population.
    Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-024-11342.
    PubMed     Abstract available
    
    
    
85. KIDOH M, Oda S, Sueta D, Egashira K, et al
    Serial assessment of coronary artery inflammation using cardiac CT in anthracycline chemotherapy for breast cancer.
    Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-025-11347.
    PubMed     Abstract available
    
    
    
86. KREGTING L, van den Oever D, Pennings L, Pijnappel R, et al
    The Screening Tomosynthesis Trial with Advanced Reader Methods (STREAM): design and rationale of a population-based breast cancer screening trial.
    Eur Radiol. 2025 Jan 9. doi: 10.1007/s00330-024-11324.
    PubMed     Abstract available
    
    
    
87. PAYNE NR, Hickman SE, Black R, Priest AN, et al
    Breast density effect on the sensitivity of digital screening mammography in a UK cohort.
    Eur Radiol. 2025;35:177-187.
    PubMed     Abstract available
    
    
    
88. KIM H, Chi SA, Kim K, Han BK, et al
    Ultrafast sequence-based prediction model and nomogram to differentiate additional suspicious lesions on preoperative breast MRI.
    Eur Radiol. 2025;35:188-201.
    PubMed     Abstract available
    
    
    
89. SOMMER A, Weigel S, Hense HW, Gerss J, et al
    Radiation exposure and screening yield by digital breast tomosynthesis compared to mammography: results of the TOSYMA Trial breast density related.
    Eur Radiol. 2025;35:166-176.
    PubMed     Abstract available
    
    
    
90. ZHOU J, Liu H, Miao H, Ye S, et al
    Breast lesions on MRI in mass and non-mass enhancement: Kaiser score and modified Kaiser score + for readers of variable experience.
    Eur Radiol. 2025;35:140-150.
    PubMed     Abstract available
    
    
    December 2024
91. NETTI S, D'Ecclesiis O, Corso F, Botta F, et al
    Methodological issues in radiomics: impact on accuracy of MRI for predicting response to neoadjuvant chemotherapy in breast cancer.
    Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11260.
    PubMed     Abstract available
    
    
    November 2024
92. HOFF SR
    Challenges when comparing tomosynthesis and 2D mammography in breast cancer screening.
    Eur Radiol. 2024 Nov 21. doi: 10.1007/s00330-024-11180.
    PubMed    
    
    
    
93. MANN RM, Rubio IT, Menke-van der Houven van Oordt CW, Fuchsjager M, et al
    ESR Bridges: image-guided breast cancer treatment de-escalation-a multidisciplinary view.
    Eur Radiol. 2024 Nov 20. doi: 10.1007/s00330-024-11208.
    PubMed    
    
    
    
94. THOMASSIN-NAGGARA I, Kilburn-Toppin F, Athanasiou A, Forrai G, et al
    Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 1: The role of common errors in radiology in missed breast cancer and implications of misdiagnosis.
    Eur Radiol. 2024 Nov 15. doi: 10.1007/s00330-024-11128.
    PubMed     Abstract available
    
    
    October 2024
95. KELLER AH, Fowler AM
    Balancing early detection with lactation-related challenges: breast MRI for high-risk breast cancer screening.
    Eur Radiol. 2024 Oct 31. doi: 10.1007/s00330-024-11129.
    PubMed    
    
    
    
96. GIANNOTTI E, Lambertini M
    Further insights into the use of contrast-enhanced imaging for breast cancer follow-up: the pros view.
    Eur Radiol. 2024 Oct 16. doi: 10.1007/s00330-024-11096.
    PubMed    
    
    
    
97. WALLIS MG
    Further insights into the use of contrast-enhanced imaging for breast cancer follow-up: the cons view.
    Eur Radiol. 2024 Oct 15. doi: 10.1007/s00330-024-11097.
    PubMed    
    
    
    
98. LIBESMAN S, Li T, Marinovich ML, Seidler AL, et al
    Interval breast cancer rates for tomosynthesis vs mammography population screening: a systematic review and meta-analysis of prospective studies.
    Eur Radiol. 2024 Oct 3. doi: 10.1007/s00330-024-11085.
    PubMed     Abstract available
    
    
    
99. HONDA M, Kataoka M
    Quantitative evaluation of breast lesions using ultrafast MRI has come so far.
    Eur Radiol. 2024;34:6283-6284.
    PubMed    
    
    
    
100. BERG WA
     Why don't all women with extremely dense breasts want MRI screening?
     Eur Radiol. 2024;34:6332-6333.
     PubMed    
     
     
     
101. BITENCOURT AGV
     The impact of AI implementation in mammographic screening: redefining dense breast screening practices.
     Eur Radiol. 2024;34:6296-6297.
     PubMed    
     
     
     
102. VEENHUIZEN SGA, van Grinsven SEL, Laseur IL, Bakker MF, et al
     Re-attendance in supplemental breast MRI screening rounds of the DENSE trial for women with extremely dense breasts.
     Eur Radiol. 2024;34:6334-6347.
     PubMed     Abstract available
     
     
     
103. KIM HJ, Kim HH, Kim KH, Lee JS, et al
     Use of a commercial artificial intelligence-based mammography analysis software for improving breast ultrasound interpretations.
     Eur Radiol. 2024;34:6320-6331.
     PubMed     Abstract available
     
     
     
104. VANCOILLIE L, Cockmartin L, Lueck F, Marshall N, et al
     Optimized signal of calcifications in wide-angle digital breast tomosynthesis: a virtual imaging trial.
     Eur Radiol. 2024;34:6309-6319.
     PubMed     Abstract available
     
     
     
105. BERGAN MB, Larsen M, Moshina N, Bartsch H, et al
     AI performance by mammographic density in a retrospective cohort study of 99,489 participants in BreastScreen Norway.
     Eur Radiol. 2024;34:6298-6308.
     PubMed     Abstract available
     
     
     
106. AMITAI Y, Freitas VAR, Golan O, Kessner R, et al
     The diagnostic performance of ultrafast MRI to differentiate benign from malignant breast lesions: a systematic review and meta-analysis.
     Eur Radiol. 2024;34:6285-6295.
     PubMed     Abstract available
     
     
     
107. GOULAM-HOUSSEIN S, Ye XY, Fleming R, Au F, et al
     Evaluating persistent T1-weighted lesions without concurrent abnormal enhancement on breast MRI in neoadjuvant chemotherapy patients: implications for complete pathological response.
     Eur Radiol. 2024;34:6273-6282.
     PubMed     Abstract available
     
     
     September 2024
108. OZCAN BB, Wanniarachchi H, Mason RP, Dogan BE, et al
     Current status of optoacoustic breast imaging and future trends in clinical application: is it ready for prime time?
     Eur Radiol. 2024;34:6092-6107.
     PubMed     Abstract available
     
     
     August 2024
109. VAN DER VOORT A, van der Hoogt KJJ, Wessels R, Schipper RJ, et al
     Correction: Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer.
     Eur Radiol. 2024 Aug 13. doi: 10.1007/s00330-024-11008.
     PubMed    
     
     
     
110. KLEIN WOLTERINK F, Ab Mumin N, Appelman L, Derks-Rekers M, et al
     Diagnostic performance of 3D automated breast ultrasound (3D-ABUS) in a clinical screening setting-a retrospective study.
     Eur Radiol. 2024;34:5451-5460.
     PubMed     Abstract available
     
     
     
111. SCHIAFFINO S, Cozzi A, Clauser P, Giannotti E, et al
     Current use and future perspectives of contrast-enhanced mammography (CEM): a survey by the European Society of Breast Imaging (EUSOBI).
     Eur Radiol. 2024;34:5439-5450.
     PubMed     Abstract available
     
     
     
112. PULIDO-CARMONA C, Romero-Martin S, Raya-Povedano JL, Cara-Garcia M, et al
     Interval cancer in the Cordoba Breast Tomosynthesis Screening Trial (CBTST): comparison of digital breast tomosynthesis plus digital mammography to digital mammography alone.
     Eur Radiol. 2024;34:5427-5438.
     PubMed     Abstract available
     
     
     July 2024
113. FALLENBERG EM
     Implementing the advantages of contrast-enhanced mammography and contrast-enhanced breast MRI in breast cancer staging.
     Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10896.
     PubMed    
     
     
     
114. SARTOR H, Sturesdotter L, Larsson AM, Rosendahl AH, et al
     Mammographic features differ with body composition in women with breast cancer.
     Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10937.
     PubMed     Abstract available
     
     
     
115. VAN DER VOORT A, van der Hoogt KJJ, Wessels R, Schipper RJ, et al
     Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer.
     Eur Radiol. 2024 Jul 5. doi: 10.1007/s00330-024-10857.
     PubMed     Abstract available
     
     
     
116. DUIJM LEM
     Dense breasts at breast cancer screening: can DWI-based breast MRI without contrast help us in the pursuit of personalized screening?
     Eur Radiol. 2024;34:4727-4729.
     PubMed    
     
     
     
117. WANG X, Jing L, Yan L, Wang P, et al
     A conditional inference tree model for predicting cancer risk of non-mass lesions detected on breast ultrasound.
     Eur Radiol. 2024;34:4776-4788.
     PubMed     Abstract available
     
     
     
118. NISSAN N
     Pre-injection anticipation of artifacts in contrast-enhanced breast MRI: artificial intelligence harnessed for the aid once again.
     Eur Radiol. 2024;34:4750-4751.
     PubMed    
     
     
     
119. CHEN C, Turco S, Kapetas P, Mann R, et al
     Spatiotemporal analysis of contrast-enhanced ultrasound for differentiating between malignant and benign breast lesions.
     Eur Radiol. 2024;34:4764-4773.
     PubMed     Abstract available
     
     
     
120. LIEBERT A, Das BK, Kapsner LA, Eberle J, et al
     Smart forecasting of artifacts in contrast-enhanced breast MRI before contrast agent administration.
     Eur Radiol. 2024;34:4752-4763.
     PubMed     Abstract available
     
     
     
121. GENNARO G, Povolo L, Del Genio S, Ciampani L, et al
     Using automated software evaluation to improve the performance of breast radiographers in tomosynthesis screening.
     Eur Radiol. 2024;34:4738-4749.
     PubMed     Abstract available
     
     
     
122. WIELEMA M, Sijens PE, Pijnappel RM, De Bock GH, et al
     Image quality of DWI at breast MRI depends on the amount of fibroglandular tissue: implications for unenhanced screening.
     Eur Radiol. 2024;34:4730-4737.
     PubMed     Abstract available
     
     
     June 2024
123. MORAN CJ
     Ready the treasure at our feet, MRI feature analysis in young women with breast cancer.
     Eur Radiol. 2024 Jun 19. doi: 10.1007/s00330-024-10840.
     PubMed    
     
     
     
124. PEDICONI F, Maroncelli R, Pasculli M, Galati F, et al
     Performance of MRI for standardized lymph nodes assessment in breast cancer: are we ready for Node-RADS?
     Eur Radiol. 2024 Jun 12. doi: 10.1007/s00330-024-10828.
     PubMed     Abstract available
     
     
     
125. EL KHOURY M, Mesurolle B
     Pre-operative MRI in patients with ductal carcinoma in situ: the ongoing debate.
     Eur Radiol. 2024;34:3967-3969.
     PubMed    
     
     
     
126. COZZI A, Di Leo G, Houssami N, Gilbert FJ, et al
     Preoperative breast MRI positively impacts surgical outcomes of needle biopsy-diagnosed pure DCIS: a patient-matched analysis from the MIPA study.
     Eur Radiol. 2024;34:3970-3980.
     PubMed     Abstract available
     
     
     
127. WAUGH J, Evans J, Miocevic M, Lockie D, et al
     Performance of artificial intelligence in 7533 consecutive prevalent screening mammograms from the BreastScreen Australia program.
     Eur Radiol. 2024;34:3947-3957.
     PubMed     Abstract available
     
     
     
128. KUHL J, Elhakim MT, Stougaard SW, Rasmussen BSB, et al
     Population-wide evaluation of artificial intelligence and radiologist assessment of screening mammograms.
     Eur Radiol. 2024;34:3935-3946.
     PubMed     Abstract available
     
     
     
129. SKAANE P, Osteras BH, Yanakiev S, Lie T, et al
     Discordant and false-negative interpretations at digital breast tomosynthesis in the prospective Oslo Tomosynthesis Screening Trial (OTST) using independent double reading.
     Eur Radiol. 2024;34:3912-3923.
     PubMed     Abstract available
     
     
     
130. KIM HJ, Choi WJ, Gwon HY, Jang SJ, et al
     Improving mammography interpretation for both novice and experienced readers: a comparative study of two commercial artificial intelligence software.
     Eur Radiol. 2024;34:3924-3934.
     PubMed     Abstract available
     
     
     May 2024
131. CHAE EY, Jung MR, Cha JH, Shin HJ, et al
     A predictive model using MRI and clinicopathologic features for breast cancer recurrence in young women treated with upfront surgery.
     Eur Radiol. 2024 May 24. doi: 10.1007/s00330-024-10805.
     PubMed     Abstract available
     
     
     
132. ALVAREZ-BENITO M
     Imaging evaluation of neoadjuvant breast cancer treatment: where do we stand?
     Eur Radiol. 2024 May 16. doi: 10.1007/s00330-024-10799.
     PubMed    
     
     
     
133. FU Y, Lei YT, Huang YH, Mei F, et al
     Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study.
     Eur Radiol. 2024 May 10. doi: 10.1007/s00330-024-10786.
     PubMed     Abstract available
     
     
     
134. ZUIANI C, Mansutti I, Caronia G, Linda A, et al
     Added value of the EUSOBI diffusion levels in breast MRI.
     Eur Radiol. 2024;34:3352-3363.
     PubMed     Abstract available
     
     
     
135. WANG L, Wang P, Shao H, Li J, et al
     Role of contrast-enhanced mammography in the preoperative detection of ductal carcinoma in situ of the breasts: a comparison with low-energy image and magnetic resonance imaging.
     Eur Radiol. 2024;34:3342-3351.
     PubMed     Abstract available
     
     
     April 2024
136. YAN R, Murakami W, Mortazavi S, Yu T, et al
     Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI.
     Eur Radiol. 2024 Apr 29. doi: 10.1007/s00330-024-10758.
     PubMed     Abstract available
     
     
     
137. MARCON M, Fuchsjager MH, Clauser P, Mann RM, et al
     ESR Essentials: screening for breast cancer - general recommendations by EUSOBI.
     Eur Radiol. 2024 Apr 24. doi: 10.1007/s00330-024-10740.
     PubMed     Abstract available
     
     
     
138. VEDANTHAM S
     Contrast-enhanced breast computed tomography: can lymph node metastasis be predicted from primary tumor?
     Eur Radiol. 2024;34:2574-2575.
     PubMed    
     
     
     
139. XU Z, Lin Y, Huo J, Gao Y, et al
     A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment.
     Eur Radiol. 2024;34:2608-2618.
     PubMed     Abstract available
     
     
     
140. MAO C, Hu L, Jiang W, Qiu Y, et al
     Discrimination between human epidermal growth factor receptor 2 (HER2)-low-expressing and HER2-overexpressing breast cancers: a comparative study of four MRI diffusion models.
     Eur Radiol. 2024;34:2546-2559.
     PubMed     Abstract available
     
     
     March 2024
141. CAMPS-HERRERO J, Pijnappel R, Balleyguier C
     MR-contrast enhanced mammography (CEM) for follow-up of breast cancer patients: a "pros and cons" debate.
     Eur Radiol. 2024 Mar 15. doi: 10.1007/s00330-024-10684.
     PubMed     Abstract available
     
     
     February 2024
142. KOCH HW, Larsen M, Bartsch H, Martiniussen MA, et al
     How do AI markings on screening mammograms correspond to cancer location? An informed review of 270 breast cancer cases in BreastScreen Norway.
     Eur Radiol. 2024 Feb 23. doi: 10.1007/s00330-024-10662.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum